AML3D LIMITED — Capital/Financing Update 2024

Apr 2, 2024

ASX Release 3 April 2024

==> picture [52 x 47] intentionally omitted <==

AML3D TO ESTABLISH USA FACILITY TO DRIVE GROWTH FOLLOWING $3.9M CAPITAL RAISE

• In the last year, AML3D has been successful in winning contracts in the US Defence sector.

• In support of these contracts and with a view to increasing its sales pipeline and expanding its contracts in the US, AML3D plans to establish a US operations base.

• 1:3 rights issue to raise $3.9m at $0.05 per share with opportunity for shareholders to apply for additional shares.

• Funds will also be used to invest in AML3D’s advanced manufacturing technology to increase its strategic position in the US Defence sector.

AML3D Limited (ASX:AL3) (" AML3D " or " the Company ") is pleased to confirm that it is intending to establish a standalone, fully operational facility in Ohio to increase the Company’s capacity to take advantage of the strong and growing demand in the US for advanced manufacturing technology solutions, notably within the US Defence industry.

To fund the expansion, AML3D will be conducting a non-renounceable rights issue on a 1:3 basis to raise up to $3.9 million at $0.05 per share.

Establish a US headquarters and manufacturing hub.

The Ohio based manufacturing facility will house AML3D’s US headquarters and operating facility. The US facility will be led by the recently appointed President of US Operations, Mr Pete Goumas and will build AML3D’s ARCEMY[®] advanced manufacturing systems; fulfill contract manufacturing, alloy testing and prototyping contracts and house AML3D’s US sales and operating functions.

Following successful completion of the capital raise AML3D will be positioned to rapidly scale up its US employee base to meet the strong and growing demand in the US for advanced manufacturing technology solutions.

Invest in AML3D’s technology.

AML3D will also invest in its software and technology to maintain the Company’s competitive advantage and increase the applications of its Wire-Arc Additive Manufacturing solutions, particularly in support of the US Defence sector. This investment will include expanding AML3D’s software development expertise and capabilities to build out new features that will enhance AML3D’s ARCEMY[® ] platform in both build size and speed and maintain its position as a market leading advance additive manufacturing solution.

Page Page | 1

AML3D Limited (ASX:AL3) ACN 602 857 983 | Australian Patent 2019251514

ASX Release 3 April 2024

==> picture [52 x 47] intentionally omitted <==

AML3D Managing Director, Sean Ebert, commented “ In CY2023, the first year of AML3D’s US scale up strategy, the Company secured ~$11.9 million in US Defence contracts alone and we continue to see surging demand in the US for our technology. The completion of this capital raising will provide the funds to establish a US manufacturing and US national sales team in Ohio to ensure we can take full advantage of this surging demand.

Our Ohio based facility will offer greater support to the US Defence sector, ensure we are best positioned to continue to win US Defence contracts and have a springboard from which to enter the additional US manufacturing sectors we have targeted, including Marine, Oil & Gas and Aerospace.

A secondary but important use of the funds to be raised is for investment to continue to develop our software and technology. Our success to date has been built around AML3D’s market leading Wire-Arc Additive Manufacturing solutions meeting the needs of the US Defence sector, particularly the US Navy’s submarine industrial base. The continued investment in our technology is designed to maintain that competitive advantage, to drive growth and create long-term value for our existing and new shareholders. ”

CAPITAL RAISING

AML3D will conduct a non-renounceable rights issue on a 1:3 basis to raise approximately $3.9 million (before costs) at an issue price of $0.05 per share ( Rights Issue ).

Existing shareholders with a registered address in Australia or New Zealand will be offered the opportunity to purchase one (1) new share for every three (3) shares held by them as at the record date of 8 April 2024. The Rights Issue price reflects an approximately 23.1% discount to the theoretical ex-rights price (TERP) of $0.065 and a 14.3% discount to the 30day volume weighted average price (VWAP) of $0.07 of the Company’s shares.

The Company will apply to ASX for official quotation of the shares issued pursuant to the Rights Issue. Based on the Company’s current issued capital, the maximum number of shares that may be issued under the Rights Issue is 78,517,904.

The offer is scheduled to open on 11 April 2024 and close on 9 May 2024. Subject to the Listing Rules, the Directors reserve the right to extend the closing date for the offer at their discretion. Should this occur, the extension will have a consequential effect on the anticipated date of issue of the new securities. The Company has decided that it is unreasonable to make the offer to shareholders who have a registered address in a country outside of Australia or New Zealand, having regard to the number of shareholders in such places, the number and value of the new shares they would be offered and the substantial costs of complying with the legal and regulatory requirements in those jurisdictions.

If after the closing date, there is a shortfall under the rights issue, the Board may in its discretion, place the shortfall with existing shareholders, institutions and other prospective investors in accordance with the ASX Listing Rules. Provision will be made for eligible shareholders to apply for additional shares beyond their entitlement on the Entitlement and Acceptance Form, which is expected to be despatched on 11 April 2024.

Page Page | 2

AML3D Limited (ASX:AL3) ACN 602 857 983 | Australian Patent 2019251514

ASX Release 3 April 2024

==> picture [52 x 47] intentionally omitted <==

APPLICATION OF FUNDS

Utilising both existing cash and proceeds from the Rights Issue, AML3D will fund the establishment of AML3D’s US headquarters and manufacturing facility to take advantage of the demand in the US for AML3D’s advanced manufacturing technology.

In addition, approximately A$0.5 million will be used to invest in AML3D’s market leading advanced Wire-Arc Manufacturing Technology and ARCEMY® platform software. The balance of funds from the Rights Issue will be used to fund working capital, to accelerate growth opportunities, and fund offer costs.

INDICATIVE TIMETABLE

Event	Date
Announcement of Rights Issue. Appendix 3B lodged.	3-Apr-24
‘Ex’ Date	5-Apr-24
Record Date for Rights Issue	8-Apr-24
Despatch of Offer Booklet and personalised entitlement and acceptance forms to persons entitled and announcement and Rights Issue opens	11-Apr-24
ClosingDate of Rights Issue	9-May-24
New Sharesquoted on deferred settlement basis	10-May-24
Announcement of results of Rights Issue and shortfall (if any) and issue of new Shares under the Rights Issue	Before noon on 16-May-24
Quotation of new Shares issued under the Rights Issue on ASX	21-May-24
Despatch date for issuer sponsored holding statements and CHESS notices in relation to the new Shares issued under the Rights Issue	24-May-24

* The dates in this table are indicative only and the Company reserves the right to vary these dates, subject to the Corporations Act 2001 (Cth), ASX Listing Rules and other applicable laws.

This announcement has been authorised for release by the Board of AML3D.

For further information, please contact:

Sean Ebert Managing Director AML3D Limited T: +61 8 8258 2658 E: investor@aml3d.com

Hamish McEwin Chief Financial Officer AML3D Limited T: +61 8 8258 2658 E: investor@aml3d.com

Page Page | 3

AML3D Limited (ASX:AL3) ACN 602 857 983 | Australian Patent 2019251514

ASX Release 3 April 2024

==> picture [52 x 47] intentionally omitted <==

About AML3D Limited

AML3D Limited, a publicly listed technology company founded in 2014, is disrupting metal part supply chains using the Company’s patented Wire Additive Manufacturing (WAM®) process. WAM® combines state-of-the-art welding science, robotics automation, materials engineering and proprietary software to lead metal additive manufacturing globally. AML3D is the OEM of the ARCEMY® industrial metal 3D printing systems. ARCEMY® uses WAM® to provide advanced, automated, on-demand, point-of-need 3D manufacturing solutions that are more efficient, cost-effective and have better ESG outcomes compared to traditional casting, forging and billet machining processes. ARCEMY® is IIoT and Industry 4.0 enabled to allow manufacturers across Aerospace, Defence, Maritime, Manufacturing, Mining and Oil & Gas to become globally competitive. AML3D also provides metal 3D printing design engineering services, software licencing, technical support, consumable sales and contract manufacturing services.

Page Page | 4

AML3D Limited (ASX:AL3) ACN 602 857 983 | Australian Patent 2019251514